- Home
- GILT vs OLMA Comparison
GILT vs OLMA Comparison
Compare GILT & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GILT | OLMA |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 747.5M | 725.5M |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GILT | OLMA |
|---|---|---|
| Price | $12.30 | $35.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $16.00 | ★ $40.50 |
| AVG Volume (30 Days) | 543.1K | ★ 8.5M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.22 | N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $392,826,000.00 | N/A |
| Revenue This Year | $49.48 | N/A |
| Revenue Next Year | $13.61 | N/A |
| P/E Ratio | $30.72 | ★ N/A |
| Revenue Growth | ★ 29.68 | N/A |
| 52 Week Low | $5.30 | $2.86 |
| 52 Week High | $15.24 | $33.50 |
Technical Indicators
Market Signals| Indicator | GILT | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.27 | 85.06 |
| Support Level | $11.91 | $25.62 |
| Resistance Level | $13.08 | $33.50 |
| Average True Range (ATR) | 0.46 | 2.32 |
| MACD | 0.17 | 0.40 |
| Stochastic Oscillator | 59.90 | 95.09 |
Price Performance
Historical ComparisonAbout GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.